These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1647 related articles for article (PubMed ID: 34876056)
1. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma. Han C; Zhang C; Wang H; Li K; Zhao L BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056 [TBL] [Abstract][Full Text] [Related]
2. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
3. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma. Song Z; Su M; Li X; Xie J; Han F; Yao J BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437 [TBL] [Abstract][Full Text] [Related]
4. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients. Zha Z; Zhang P; Li D; Liu G; Lu L Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217 [TBL] [Abstract][Full Text] [Related]
5. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma. Yang B; Wang Y; Liu T; Zhang M; Luo T Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403 [TBL] [Abstract][Full Text] [Related]
6. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer. Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844 [TBL] [Abstract][Full Text] [Related]
7. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma. He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526 [TBL] [Abstract][Full Text] [Related]
8. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration. Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R Front Immunol; 2022; 13():854785. PubMed ID: 35392086 [TBL] [Abstract][Full Text] [Related]
9. Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance. Lu L; Yu M; Huang W; Chen H; Jiang G; Li G Libyan J Med; 2023 Dec; 18(1):2220153. PubMed ID: 37300839 [TBL] [Abstract][Full Text] [Related]
10. Construction of store-operated calcium entry-related gene signature for predicting prognosis and indicates immune microenvironment infiltration in stomach adenocarcinomas. Zhang Z; Wang C; Shi W; Wang Z; Fu W Sci Rep; 2024 Sep; 14(1):22342. PubMed ID: 39333689 [TBL] [Abstract][Full Text] [Related]
11. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma. Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081 [TBL] [Abstract][Full Text] [Related]
12. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Yu J; Mao W; Xu B; Chen M Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306 [TBL] [Abstract][Full Text] [Related]
13. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis. Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344 [TBL] [Abstract][Full Text] [Related]
14. Construction of a Prognostic Evaluation Model for Stomach Adenocarcinoma on the Basis of Immune-Related lncRNAs. Xu C; Chen Z; Pan X; Liu M; Cheng G; Li J; Mei Y Appl Biochem Biotechnol; 2022 Dec; 194(12):6255-6269. PubMed ID: 35904674 [TBL] [Abstract][Full Text] [Related]
15. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
16. Prognostic thirteen-long non-coding RNAs (IncRNAs) could improve the survival prediction of gastric cancer. Zong Z; Li H; Yu ZM; Tang FX; Zhu XJ; Tian HK; Zhou TC; Wang H Gastroenterol Hepatol; 2020 Dec; 43(10):598-606. PubMed ID: 32674880 [TBL] [Abstract][Full Text] [Related]
17. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K Front Immunol; 2022; 13():947802. PubMed ID: 36405735 [TBL] [Abstract][Full Text] [Related]
18. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer. Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686 [TBL] [Abstract][Full Text] [Related]
19. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction. Hu X; Wu L; Liu B; Chen K Front Immunol; 2021; 12():651056. PubMed ID: 34122409 [TBL] [Abstract][Full Text] [Related]
20. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma. Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]